Back to homepage

Tag "SGLT2 inhibitors"

Diabetes: how to manage cardiovascular risk in secondary prevention patients

Authors: Sarah L Anderson, Joel C Marrs

This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.


Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions

Authors: Sarah L Anderson, Matteo Bassetti, Arduino A Mangoni

The Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021.